Table 3. Multivariate analysis of clinical outcome by Cox proportional hazards model.
Disease-free survival
|
Overall survival
|
|||
---|---|---|---|---|
Variables | HR (95% CI) | P -value | HR (95% CI) | P -value |
TOP2B/TOP2A ratio | ||||
High (⩾1.0, N=21) | 1 | 1 | ||
Low (<1.0, N=33) | 4.17 (1.73–10.10) | 0.002 | 3.4 (1.5–8.1) | 0.005 |
Cytogenetics | 0.035 | |||
Normal (N=16) | 1 | |||
t(8;21) (N=24) | 0.45 (0.17–1.15) | 0.094 | — | — |
Others (N=14) | 1.35 (0.51–3.61) | 0.544 | — | — |
Abbreviations: CI=confidence interval; HR=hazard ratio.
Gene markers and clinical factors, for example, RRM2, TOP2B, TOP2B/RRM2, TOP2B/TOP2A, age, cytogenetics and HSCT, which displayed P-value <0.2 in univariate analysis, were considered in this analysis. Exceptively, we included TOP2A in the variables even though a predictive significance of this gene was not satisfied to our criteria in univariate analysis. Shown are the variables remaining only in a final model of the Cox proportional hazard model with a stepwise forward method.